Number of Lymph Node Metastases Is a Significant Prognostic Factor in Intrahepatic Cholangiocarcinoma

Department of General Surgery, Hokkaido University, Graduate School of Medicine, N15W7, Kita-ku, Sapporo, Japan.
World Journal of Surgery (Impact Factor: 2.35). 07/2005; 29(6):728-33. DOI: 10.1007/s00268-005-7761-9
Source: PubMed

ABSTRACT Intrahepatic cholangiocarcinoma (IHCC) is a rare primary hepatic tumor. Outcomes after resection and the use of lymph node dissection have not been well described. From a prospective database, we identified 53 patients with IHCC who underwent exploration between April 1983 and March 2004. Hepatic resection was performed in 44 patients, 30 of whom underwent lymph node dissection. Clinicopathological features and outcomes were analyzed. The actuarial 1-year survival was 66.2% in resected patients, compared to 0% in unresectable patients (p < 0.0001), with a 50% overall survival of 21.5 months and 3.1 months, respectively. The actuarial 3-year and 5-year overall survival rates in resected patients were 38.3% and 26.3%, respectively. Univariate analysis revealed that factors associated with poor overall survival included multiple tumors, extrahepatic bile duct involvement, noncurative resection, and involvement of lymph nodes. Multivariate analysis in resected patients revealed that multiple tumors (p < 0.0074) and non-curative resection (p = 0.0068) were significant risk factors for poor overall survival. The survival rate in patients with three or more positive nodes was significantly lower than in those with fewer than three (p < 0.0001). Three patients with solitary tumors and one or two involved lymph nodes have survived beyond 4 years after extended lobectomy with systemic lymphadenectomy. Curative resection, single tumor, and fewer than two lymph node metastases were prognostic factors for good outcome. Curative resection with lymph node dissection improved survival in patients with no more than two positive lymph nodes.

  • Source
    • "While removal of clinically suspicious nodal disease is mandatory , the role of routine lymphadenectomy is less defined. In contrast to the practice of many Japanese centers, lymph node dissection is not routinely performed at the time of iCCA resection in most Western countries [156]. In fact, in a large population-based "
    Journal of Hepatology 06/2014; 60(6). DOI:10.1016/j.jhep.2014.01.021 · 10.40 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: A full digital RF field control module (FCM) has been developed for SNS LINAC. The digital hardware for all the control and DSP functionalities, including the final vector modulation as well as IF output synthesis, is implemented on a single high-density FPGA. Two of its HDL models have been written in VHDL and Verilog respectively, and both have being used to support the testing and commissioning of the LINAC to the date. The control algorithm used in the HDL produces a latency as low as 150nS. During the commissioning, the flexibility and capacity for needed precise controls that only digital design can provide has proved to be a necessity for meeting the great challenge of a high-power pulsed SCL.
    Particle Accelerator Conference, 2005. PAC 2005. Proceedings of the; 06/2005
  • [Show abstract] [Hide abstract]
    ABSTRACT: We performed hepatectomy without lymph node (LN) dissection for intrahepatic cholangiocarcinoma (ICC) limited to the peripheral region of the liver, and hepatectomy with extrahepatic bile duct resection and regional LN dissection for any types of ICC extending to the hepatic hilum. Surgical outcomes were evaluated to elucidate the prognostic factors that influence patient survival with respect to intrahepatic recurrence. Forty-one patients underwent resection of ICC with no macroscopic evidence of residual cancer. Significant risk factors for poorer survival included preoperative jaundice (P = 0.0115), serum CA19-9 levels >37 U/ml (P = 0.0089), tumor diameter >4.5 cm (P = 0.017), ICC extending to the hepatic hilum (P = 0.0065), mass-forming with periductal-infiltrating type (P = 0.003), poorly differentiated adenocarcinoma, portal vein involvement (P = 0.0785), LN metastasis at initial hepatectomy (P < 0.0001), and positive surgical margin (P = 0.023). Intrahepatic recurrence, which was the predominant manner of recurrence, was detected in 20 patients (74.1%). Patients with intrahepatic recurrence had a significantly high incidence of high serum CA19-9 levels (>37 U/ml; P = 0.0006), preoperative jaundice (P = 0.0262), ICC extended to the hepatic hilum (P = 0.0349), large tumors (>4.5 cm; P = 0.0351), portal vein involvement (P = 0.0423), and LN metastasis at initial hepatectomy (P = 0.009) compared with disease-free patients. The multiple logistic regression analysis revealed that preoperative CA19-9 elevation and obstructive jaundice influenced intrahepatic recurrence of ICC. Although LN metastasis is a significant prognostic factor, the most obvious recurrence pattern after surgery was intrahepatic recurrence, which could be predicted preoperatively by a combination of elevated serum CA19-9 levels and manifestation of obstructive jaundice.
    Journal of Gastroenterology 10/2006; 41(9):893-900. DOI:10.1007/s00535-006-1877-z · 4.02 Impact Factor
Show more